Home

Fan Yu

CIK 1668029 · Chief Executive Officer · last filed 2023-06-21

Fan Yu is a Chief Executive Officer who has filed 5 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for MDVL, was dated Jun 21, 2023. Across all open-market trades the lifetime net is +$11.3M, making them a net buyer over the disclosed history. 14 SEC filings were submitted jointly with Ally Bridge LB Management Ltd.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

5

Lifetime Open-Market Net

$11.26M

Filer Profile

Reported Address
SUITE 3902, 39/F, EAST TOWER
CHEUNG KONG CNTR II, 10 HARCOURT ROAD
CENTRAL, HONG KONG 000000
Related Filers
Ally Bridge LB Management Ltd — 14 joint filings, latest 2018-09-14
Bin Li — 14 joint filings, latest 2018-09-14
ABG Management Ltd. — 13 joint filings, latest 2026-02-05
Ally Bridge Group (NY) LLC — 13 joint filings, latest 2026-02-05
Ally Bridge MedAlpha Master Fund L.P. — 13 joint filings, latest 2026-02-05
ABG Management Ltd — 11 joint filings, latest 2018-09-14
ABG-WTT Global Life Science Capital Partners GP Ltd — 10 joint filings, latest 2023-06-21
ABG II-SO Ltd — 9 joint filings, latest 2018-09-14
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MedAvail Holdings, Inc. (MDVL) Delisted 10%+ Owner 57,356 $1.80 $103.2K $11.26M 3 2023-06-21
ABG Acquisition Corp. I (ABGI) Delisted Chief Executive Officer 501,300 $10.19 $5.11M $0 1 2021-09-13

Recent Filings

5 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-06-21 MedAvail Holdings, Inc. (MDVL) Delisted Other (J) — $0 EDGAR
2023-03-03 — Disp (D) −501,300 $0
2021-09-13 ABG Acquisition Corp. I (ABGI) Delisted Other (J) +39,300 $393.0K EDGAR
2020-12-18 MedAvail Holdings, Inc. (MDVL) Delisted Buy (P) +433,830 $5.70M EDGAR
2020-12-16 MedAvail Holdings, Inc. (MDVL) Delisted Buy (P) +438,860 $5.56M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.